A recent meta-analysis by Vuong et al. supports the hypothesis that lower adiponectin levels in obese individuals may contribute to the development of inflammation and insulin resistance [83], which are recognized risk factors for depression [84]. Here, ADIPOQ is linked to major depressive disorder.